title: Autoimmune hemolytic anemias and IgG antierythrocyte autoantibodies in Waldenström's macroglobulinemia: association with FcgammaRIIa polymorphism.
authors.forename: S
authors.initials: S
authors.lastname: Poulain
authors.forename: I
authors.initials: I
authors.lastname: Dervite
authors.forename: X
authors.initials: X
authors.lastname: Leleu
authors.forename: J
authors.initials: J
authors.lastname: Fernandes
authors.forename: L
authors.initials: L
authors.lastname: Stalnikiewicz
authors.forename: A-S
authors.initials: AS
authors.lastname: Moreau
authors.forename: V
authors.initials: V
authors.lastname: Coiteux
authors.forename: S
authors.initials: S
authors.lastname: de Botton
authors.forename: P
authors.initials: P
authors.lastname: Duthilleul
authors.forename: P
authors.initials: P
authors.lastname: Morel
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000744:Anemia, Hemolytic, Autoimmune / Q000276:immunology*; D015703:Antigens, CD / Q000235:genetics*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001323:Autoantibodies / Q000097:blood*; D004912:Erythrocytes / Q000276:immunology*; D005260:Female; D005500:Follow-Up Studies; D005838:Genotype; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D008297:Male; D008875:Middle Aged; D011110:Polymorphism, Genetic; D017452:Receptors, IgG / Q000235:genetics*; D015996:Survival Rate; D016896:Treatment Outcome; D008258:Waldenstrom Macroglobulinemia / Q000188:drug therapy / Q000235:genetics* / Q000276:immunology*
chemical_list: D015703:Antigens, CD; D001323:Autoantibodies; C080568:Fc gamma receptor IIA; D007074:Immunoglobulin G; D017452:Receptors, IgG